Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and ...

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT (MA, ...

Background: Heart failure with preserved ejection fraction (HFpEF) involves myocardial aging, inflammation, and diastolic dysfunction. Monoamine oxidase-A (MAO-A), a mitochondrial enzyme generating ...

Cancer cells are among the most numerous cell types that comprise the tumor microenvironment, but with respect to immune therapy, they are often underutilized. Stimulator of interferon genes (STING) ...

KNOXVILLE, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of independent preclinical research ...

Sepsis, a critical condition characterized by life-threatening organ dysfunction, arises from a dysregulated host response to ...

Researchers have long focused on the STING (Stimulator of Interferon Genes) pathway as a way to harness the immune system's natural defenses against cancer. This pathway, which plays a key role in ...

Summary: A rare genetic mutation known as APOE3-R136S, or the “Christchurch mutation,” appears to protect against Alzheimer’s disease by suppressing inflammatory signaling in the brain’s immune cells.

Researchers at Weill Cornell Medicine report that a rare gene mutation that delays Alzheimer’s disease does so by damping inflammatory signaling in brain-resident immune cells in a preclinical study.